By targeting NF-κB inducing kinase, miR-502e directly influences the non-canonical NF-κB pathway that affects proliferation in hepatoma cell lines and hepatocellular carcinoma [120]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.